Personalis, Inc. (PSNL)
6.58
+0.02
(+0.30%)
USD |
NASDAQ |
Apr 02, 16:00
6.57
-0.01
(-0.15%)
Pre-Market: 20:00
Personalis Research and Development Expense (TTM) : 50.26M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 379.07M |
| Hologic, Inc. | 248.50M |
| Pacific Biosciences of California, Inc. | 95.21M |
| Twist Bioscience Corp. | 76.11M |
| Ionis Pharmaceuticals, Inc. | 914.12M |